PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
Amelia BarcelliniPierre LoapKazutoshi MurataRiccardo VillaYoulia M KirovaNoriyuki OkonogiEster OrlandiPublished in: Cancers (2021)
despite the heterogeneity of the evaluated patient populations and tumor types, and the limited number of the studies, this review suggests that a combination approach is feasible even though the efficacy profile remains unclear.